By expenditures
| Name | Title | Type |
|---|---|---|
| Sarah Parker | Executive Director | Auditee |
| Sarah Parker | EXECUTIVE DIRECTOR | Auditee |
| Rich Larsen | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 337316 | 2024 | 2025-01-13 | Novogradac & Company LLP | $6.71M |
| 289581 | 2023 | 2024-02-08 | Novogradac & Company LLP | $6.26M |
| 47651 | 2022 | 2022-12-28 | Novogradac & Company LLP | $6.60M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 337316 | 2024 | 2025-01-13 | 1095330 | 2024-003 | Significant Deficiency | Yes | N |
| 337316 | 2024 | 2025-01-13 | 1095329 | 2024-002 | Significant Deficiency | Yes | N |
| 337316 | 2024 | 2025-01-13 | 1095328 | 2024-003 | Significant Deficiency | Yes | N |
| 337316 | 2024 | 2025-01-13 | 1095327 | 2024-002 | Significant Deficiency | Yes | N |
| 337316 | 2024 | 2025-01-13 | 518888 | 2024-003 | Significant Deficiency | Yes | N |
| 337316 | 2024 | 2025-01-13 | 518887 | 2024-002 | Significant Deficiency | Yes | N |
| 337316 | 2024 | 2025-01-13 | 518886 | 2024-003 | Significant Deficiency | Yes | N |
| 337316 | 2024 | 2025-01-13 | 518885 | 2024-002 | Significant Deficiency | Yes | N |
| 289581 | 2023 | 2024-02-08 | 943106 | 2023-002 | Significant Deficiency | - | N |
| 289581 | 2023 | 2024-02-08 | 943105 | 2023-001 | Material Weakness | - | N |
| 289581 | 2023 | 2024-02-08 | 366664 | 2023-002 | Significant Deficiency | - | N |
| 289581 | 2023 | 2024-02-08 | 366663 | 2023-001 | Material Weakness | - | N |